上海医药 (601607)

Shanghai Pharmaceuticals Holding Co., Ltd.

ASH

Tags

300 Non-Cyclical IndexMSCI Component StocksShanghai Free Trade ZoneSSE 180 IndexSSE Mid Cap IndexMid Cap ValueCSI 200 IndexGeneric DrugsLow Price-to-Book RatioLow Price-to-Earnings RatioInsurance Heavy PositionsInnovative DrugsPharmaceuticals and HealthcarePharmaceutical CommerceInvestments in Newly Listed CompaniesContains H-SharesGuozheng Value IndexCCTV 50 IndexSmart HealthcareCSI 300 IndexConsumption 100 IndexBiological VaccinesBelow Net Asset ValueHigh-Performing StocksMargin Trading and Securities LendingIndustry LeadersChina Securities Finance and Central Huijin HoldingsRetailNon-Cyclical StocksHigh Accounts Receivable医药生物

K-Line Chart

No K-line data available

Company NameShanghai Pharmaceutical Group Co., Ltd.
Listing Date1994-03-24
Issue Price4.5RMB
Registered Capital370836.180910k RMB
Legal RepresentativeYang Qiuhua
Registered AddressNo. 92 Zhangjiang Road, China (Shanghai) Pilot Free Trade Zone
IndustryPharmaceutical Distribution
Main BusinessProduction, sales, and import/export business of chemical raw materials, chemical drug preparations, antibiotics, biochemical drugs, biological products, traditional Chinese patent medicines, medical devices, pharmaceutical equipment, and chemical hazardous materials.
Company ProfileShanghai Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") is a large pharmaceutical industry group listed on both the Shanghai and Hong Kong stock exchanges (HKEX stock code: 02607; SSE stock code: 601607). The Company's main business covers pharmaceutical R&D and manufacturing, distribution, and retail. In 2016, its operating revenue reached 120.8 billion yuan, and its comprehensive ranking is among the top in China. It is one of the few listed pharmaceutical companies in China leading in both pharmaceutical products and the distribution market. The Company is a constituent of the SSE 180 Index, CSI 300 Index, Hang Seng Index, and the MSCI China Index.

Stock Details

1. Key Indicators

  • Total Shares(W): 370836.18
  • Circulating A-Shares(W): 278920.75
  • Earnings Per Share(RMB): 1.3900
  • Net Assets Per Share(RMB): 20.4357
  • Operating Revenue(W RMB): 21507223.04
  • Total Profit(W RMB): 829809.71
  • **Net Profit Attributable to Parent(W RMB) **: 514706.49
  • Net Profit Growth Rate(%): 26.96
  • Weighted Return on Equity(%): 6.9600
  • Operating Cash Flow Per Share(RMB): 0.6340
  • Undistributed Profit Per Share(RMB): 10.9491
  • Capital Reserve Per Share(RMB): 8.0094

2. Main Business

The main business covers:

  • Active Pharmaceutical Ingredients (APIs)
  • Pharmaceutical Preparations
  • Health Products

3. Company Basic Information

  • Company Name: Shanghai Pharmaceuticals Holding Co., Ltd.
  • Listing Date: 1994-03-24
  • Industry: Pharmaceutical Commerce
  • Address: Shanghai Pharmaceutical Building, No. 200 Taicang Road, Shanghai
  • Website: https://www.sphchina.com
  • Company Profile: The company's predecessor was Shanghai Fourth Pharmaceutical Factory. It underwent a joint-stock restructuring in 1993, converting the original company's net assets into 42.9666 million state shares. After an initial public offering from October to November of the same year, the total number of shares upon listing was 57.9666 million. The 1.5 million employee shares began trading on September 27, 1994. On August 19, 1998, the company allocated 26.16 million shares to existing shareholders at a 10:6 ratio and issued an additional 13.84 million public shares. These shares began trading on the Shanghai Stock Exchange on September 9, 1998.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shanghai Pharmaceutical (Group) Co., Ltd. General Legal Person 71651.60 25.69
2 Yunnan Baiyao Group Co., Ltd. General Legal Person 66562.68 23.86
3 Shanghai Industrial (Group) Co., Ltd. General Legal Person 22180.18 7.95
4 Shanghai Tandong Enterprise Consulting Services Co., Ltd. General Legal Person 18700.00 6.70
5 Hong Kong Securities Clearing Company Ltd. Northbound Capital 4806.11 1.72
6 China Securities Finance Corporation Ltd. Special Legal Person 4133.05 1.48
7 New China Life Insurance Co., Ltd. - Dividend - Individual Dividend - 018L-FH002 Shanghai Insurance 2902.05 1.04
8 ICBC Credit Suisse Innovation Power Equity Securities Investment Fund Fund 531.00 0.19
9 ICBC Credit Suisse Selected Balanced Hybrid Securities Investment Fund Fund 261.00 0.09
10 Yinhua Xinrui Flexible Allocation Hybrid Securities Investment Fund (LOF) Class A Fund 12.49 0.00

5. Concept Sectors

  • H-Share
  • Biological Vaccine
  • Shanghai Free Trade Zone
  • Intelligent Healthcare
  • Generic Drugs
  • Innovative Drugs

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information